Overnight news ICYMI: Gilead plans to produce two million remdesivir coronavirus course by the end of 2020

Forex

Gilead Sciences planning to produce the amount of its potential COVID-19 drug remdesivir by the end of the year 

  • It says it’ll begin trial of an easier-to-use inhaled version in August (its currently administered intravenously)
  • inhaled formulation would be via a nebulizer, whoich would make its use easier outside of in-patient at hospital

This was out overnight, not fresh news, 

Gilead Sciences planning to produce the amount of its potential COVID-19 drug remdesivir by the end of the year 

For bank trade ideas, check out eFX Plus

Let’s block ads! (Why?)

Forexlive RSS Breaking news feed

Leave a Reply

Your email address will not be published. Required fields are marked *